[Clinical study of the anticoagulant 3-(1-phenylpropyl)-4-hydroxycoumarin or marcoumar and of its antidote, vitamin K1].
D015110:4-Hydroxycoumarins; D000925:Anticoagulants; D000931:Antidotes; D003374:Coumarins / Q000031:analogs & derivatives; D005260:Female; D006490:Hemostatics; D006801:Humans; D010644:Phenprocoumon; D011517:Prothrombin Time / Q000187:drug effects*; D013924:Thrombophlebitis / Q000628:therapy*; D014812:Vitamin K / Q000494:pharmacology*; D010837:Vitamin K 1
D015110:4-Hydroxycoumarins; D000925:Anticoagulants; D000931:Antidotes; D003374:Coumarins; D006490:Hemostatics; D014812:Vitamin K; D010837:Vitamin K 1; C030123:coumarin; D010644:Phenprocoumon; C068805:4-hydroxycoumarin
COUMARIN/derivatives; PROTHROMBIN TIME/effect of drugs on; THROMBOPHLEBITIS/therapy; VITAMIN K/effects
Studio clinico dell'anticoagulante 3-(1'-fenil-propil)-4-idrossicumarina (marcumar) e del suo antidoto, vitamina K1.